Clinical Trial Update: BIOTRONIK Orsiro Pre-Marketing Registration [NA]

View source ↗

Summary

Clinical trial update for BIOTRONIK Orsiro pre-marketing registration completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Orsiro (Sirolimus-eluting stent)

Snippet

Sponsor: Biotronik (Beijing) Medical Device Ltd. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2024-03-04